French diagnostics association pushes for recognition:
This article was originally published in Clinica
Executive Summary
SFRL, the French diagnostics industry association, wants the importance of lab testing to be recognised as a basis for better decisions in healthcare. The French association has been battling against severe cuts in healthcare, is to launch a national campaign on the role of IVD in healthcare. Claude Buffard remains president of the association. Michel Doucet (bioMerieux) becomes vice-president, Jacqueline Bremond (Abbott) general secretary, and Alain Flechel (Roche) treasurer.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.